A recent prospective cross-sectional study in Thailand demonstrates that multitarget stool DNA testing is highly sensitive and specific for detecting colorectal cancer (CRC) among Thai individuals.
NexTel Medical Corp f/k/a Exousia Pro, Inc. (OTCPK: MAJI ), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is proud to announce the commencement of ...
Exact Sciences (NASDAQ:EXAS) has received approval from the U.S. Food and Drug Administration (FDA) for its non-invasive multitarget stool DNA test to detect colorectal cancer in adults ages 45 and ...
CRANSTON, R.I. (WPRI) — The Cranston Fire Department has become the first in Rhode Island to test new cancer-screening technology. EsoGuard is a non-invasive DNA test, introduced by Lucid Diagnostics, ...
Detection Market · GlobeNewswire Inc. The cell-free tumor DNA detection market is set to experience significant growth, ...
A groundbreaking noninvasive urine test is transforming how doctors predict bladder cancer treatment outcomes. This ...
This article is authored by Dr Kiran Coelho, Consultant, obstetrician-gynaecologist, Lilavati Hospital and Research Centre.
Pharmaceutical Technology on MSN
Non-invasive diagnostics in endometriosis: at the cusp of a turning point
Innovative diagnostics may reduce ~9-year diagnosis delay, but systemic barriers to implementation remain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results